Basics Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. IPO Date: September 11, 2017 Sector: Healthcare Industry: Biotech Market Cap: $258.88M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 2.49% Avg Daily Range (30 D): $0.13 | 1.74% Avg Daily Range (90 D): $0.19 | 2.28% Institutional Daily Volume Avg Daily Volume: .09M Avg Daily Volume (30 D): .14M Avg Daily Volume (90 D): .11M Trade Size Avg Trade Size (Sh.): 124 Avg Trade Size (Sh.) (30 D): 114 Avg Trade Size (Sh.) (90 D): 102 Institutional Trades Total Inst.Trades: 40 Avg Inst. Trade: $2.83M Avg Inst. Trade (30 D): $3.5M Avg Inst. Trade (90 D): $2.93M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.82M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.22M Avg Closing Volume: 709.79K     News Dec 26, 2025 @ 10:44 PM Southpoint holdings in Fennec Pharmaceuticals Inc.... Source: Na Nov 14, 2025 @ 4:11 AM Fennec Pharmaceuticals Announces Private Offering ... Source: Fennec Pharmaceuticals Inc. Nov 14, 2025 @ 4:07 AM Fennec Pharmaceuticals Announces Pricing of Offeri... Source: Fennec Pharmaceuticals Inc. Aug 14, 2025 @ 3:04 PM Fennec Q2 Sales Jump 33 Percent Source: Na Jun 3, 2025 @ 8:31 PM Fennec Announces Results of Annual Meeting Source: N/A Financials   TTM Q3 2025 Q2 2025 Basic EPS $-.26 $-.02 $-.11 Diluted EPS $-.26 $-.02 $-.11 Revenue $ 38.79M $ 12.46M $ 9.65M Gross Profit $ $ $ Net Income / Loss $ -6.94M $ -.64M $ -3.15M Operating Income / Loss $ -4.66M $ -.19M $ -2.73M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Sep 05, 2014:   1:3 Aug 30, 2011:   1:18 Aug 02, 2005:   1:5